.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Dow
Medtronic
Mallinckrodt
Healthtrust
US Army
Teva
Daiichi Sankyo
QuintilesIMS
McKinsey

Generated: September 20, 2017

DrugPatentWatch Database Preview

Zileuton - Generic Drug Details

« Back to Dashboard

What are the generic sources for zileuton and what is the scope of zileuton freedom to operate?

Zileuton
is the generic ingredient in three branded drugs marketed by Rising Pharms Inc and Chiesi Usa Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for zileuton. Three suppliers are listed for this compound.

Summary for Generic Name: zileuton

Tradenames:3
Patents:0
Applicants:2
NDAs:3
Drug Master File Entries: see list6
Suppliers / Packagers: see list3
Bulk Api Vendors: see list79
Clinical Trials: see list20
Patent Applications: see list5,573
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:zileuton at DailyMed

Pharmacology for Ingredient: zileuton

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc
ZYFLO CR
zileuton
TABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007ABRXYesYes► Subscribe► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-003Dec 9, 1996RXYesYes► Subscribe► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-001Dec 9, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Rising Pharms Inc
ZILEUTON
zileuton
TABLET, EXTENDED RELEASE;ORAL204929-001Mar 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zileuton

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc
ZYFLO CR
zileuton
TABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-003Dec 9, 1996► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-001Dec 9, 1996► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO CR
zileuton
TABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO CR
zileuton
TABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Novartis
Colorcon
Boehringer Ingelheim
McKesson
Cipla
Argus Health
Daiichi Sankyo
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot